EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Construction of an Escherichia coli chassis for efficient biosynthesis of human-like N-linked glycoproteins

Zixin Bao, Yuting Gao, Yitong Song, Ning Ding, Wei Li, Qiong Wu, Xiaomei Zhang, Yang Zheng, Junming Li, Xuejun Hu

Frontiers in Bioengineering and Biotechnology · 20.03.2024 · 12

DOI: 10.3389/fbioe.2024.1370685 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 20.03.2024. Verfasst von Zixin Bao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Academic Centre for Medical Research, Medical College, Dalian University, Dalian, China. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The production of N -linked glycoproteins in genetically engineered Escherichia coli holds significant potential for reducing costs, streamlining bioprocesses, and enhancing customization. However, the construction of a stable and low-cost microbial cell factory for the efficient production of humanized N -glycosylated recombinant proteins remains a formidable challenge. In this study, we developed a glyco-engineered E. coli chassis to produce N -glycosylated proteins with the human-like glycan Gal-β-1,4-GlcNAc-β-1,3-Gal-β-1,3-GlcNAc-, containing the human glycoform Gal-β-1,4-GlcNAc-β-1,3-. Our initial efforts were to replace various loci in the genome of the E. coli XL1-Blue strain with oligosaccharyltransferase PglB and the glycosyltransferases LsgCDEF to construct the E. coli chassis. In addition, we systematically optimized the promoter regions in the genome to regulate transcription levels. Subsequently, utilizing a plasmid carrying the target protein, we have successfully obtained N -glycosylated proteins with 100% tetrasaccharide modification at a yield of approximately 320 mg/L. Furthermore, we constructed the metabolic pathway for sialylation using a plasmid containing a dual-expression cassette of the target protein and CMP-sialic acid synthesis in the tetrasaccharide chassis cell, resulting in a 40% efficiency of terminal α-2,3- sialylation and a production of 65 mg/L of homogeneously sialylated glycoproteins in flasks. Our findings pave the way for further exploration of producing different linkages (α-2,3/α-2,6/α-2,8) of sialylated human-like N -glycoproteins in the periplasm of the plug-and-play E. coli chassis, laying a strong foundation for industrial-scale production.

Schlagwörter

Stichwörter der Autor:innen

Escherichia coli chassisN-glycosylationglycoproteinsialic acidsialylation

Autor:innen und Institutionen

  • Academic Centre for Medical Research, Medical College, Dalian University, Dalian, China.
  • Dalian Key Laboratory of Oligosaccharide Recombination and Recombinant Protein Modification, Dalian, China.
  • Department of Clinical Laboratory, Yantai Yuhuangding Hospital, Yantai, China.

Zitieren

APA

Bao, Z., Gao, Y., Song, Y., Ding, N., Li, W., Wu, Q., Zhang, X., Zheng, Y., Li, J., & Hu, X. (2024). Construction of an Escherichia coli chassis for efficient biosynthesis of human-like N-linked glycoproteins. Frontiers in Bioengineering and Biotechnology, 12. https://doi.org/10.3389/fbioe.2024.1370685

Vancouver

Bao Z, Gao Y, Song Y, Ding N, Li W, Wu Q, et al. Construction of an Escherichia coli chassis for efficient biosynthesis of human-like N-linked glycoproteins. Frontiers in Bioengineering and Biotechnology. 2024;12. doi:10.3389/fbioe.2024.1370685

BibTeX
@article{Bao2024,
  author = {Bao, Zixin and Gao, Yuting and Song, Yitong and Ding, Ning and Li, Wei and Wu, Qiong and Zhang, Xiaomei and Zheng, Yang and Li, Junming and Hu, Xuejun},
  title = {Construction of an Escherichia coli chassis for efficient biosynthesis of human-like N-linked glycoproteins},
  journal = {Frontiers in Bioengineering and Biotechnology},
  year = {2024},
  volume = {12},
  doi = {10.3389/fbioe.2024.1370685}
}
Kostenlos starten →